ストックスクリーナーアプリを入手
66.60
1.00%
0.66
アフターアワーズ：
67.50
0.90
+1.35%
前日終値:
$65.94
開ける：
$66.31
24時間の取引高:
3.84M
Relative Volume:
0.77
時価総額：
$25.63B
収益：
$4.66B
当期純損益:
$836.30M
株価収益率:
31.82
EPS:
2.093
ネットキャッシュフロー:
$1.08B
1週間 パフォーマンス:
-1.07%
1か月 パフォーマンス:
-8.88%
6か月 パフォーマンス:
-1.33%
1年 パフォーマンス:
-11.58%
1日の値動き範囲:
$65.09
$66.94
1週間の範囲:
$65.09
$68.76
52週間の値動き範囲:
$54.11
$89.98
Dexcom Inc Stock (DXCM) Company Profile
Compare DXCM vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
DXCM
Dexcom Inc
|
66.60 | 25.38B | 4.66B | 836.30M | 1.08B | 2.093 |
ABT
Abbott Laboratories
|
104.06 | 182.20B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
328.51 | 127.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.58 | 111.92B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
68.15 | 103.35B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.69 | 47.64B | 6.07B | 1.06B | 1.34B | 1.8063 |
Dexcom Inc Stock (DXCM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-01-12 | ダウングレード | Barclays | Equal Weight → Underweight |
| 2025-12-02 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2025-11-25 | 開始されました | Evercore ISI | In-line |
| 2025-10-21 | 再開されました | Stifel | Buy |
| 2025-09-08 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-08-21 | 開始されました | Argus | Buy |
| 2025-06-16 | 開始されました | Truist | Buy |
| 2025-05-30 | 開始されました | Goldman | Buy |
| 2025-04-10 | 開始されました | Mizuho | Outperform |
| 2025-02-03 | アップグレード | Redburn Atlantic | Neutral → Buy |
| 2025-01-16 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-07-26 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-26 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-05-30 | 開始されました | Redburn Atlantic | Neutral |
| 2024-03-12 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Equal-Weight |
| 2023-04-17 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2023-03-29 | 開始されました | UBS | Buy |
| 2023-01-26 | 開始されました | Wolfe Research | Outperform |
| 2022-10-18 | 開始されました | Barclays | Equal Weight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-15 | 開始されました | Bernstein | Outperform |
| 2022-03-02 | 再開されました | BofA Securities | Buy |
| 2022-02-03 | アップグレード | BTIG Research | Neutral → Buy |
| 2022-01-19 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2022-01-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2021-10-18 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-07-21 | 再開されました | Cowen | Outperform |
| 2021-05-28 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Overweight |
| 2021-01-06 | アップグレード | UBS | Neutral → Buy |
| 2020-10-02 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2020-05-27 | 繰り返されました | Piper Sandler | Overweight |
| 2020-05-14 | 開始されました | Wells Fargo | Equal Weight |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2019-11-07 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-11-07 | アップグレード | Guggenheim | Neutral → Buy |
| 2019-10-23 | 開始されました | Stifel | Buy |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-10-19 | アップグレード | Goldman | Sell → Neutral |
| 2018-09-12 | アップグレード | Northland Capital | Under Perform → Market Perform |
| 2018-08-02 | 繰り返されました | Canaccord Genuity | Buy |
| 2018-07-02 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2018-06-08 | アップグレード | JP Morgan | Neutral → Overweight |
| 2018-05-11 | 開始されました | BofA/Merrill | Buy |
| 2018-05-03 | 繰り返されました | Canaccord Genuity | Buy |
| 2018-04-04 | 開始されました | Goldman | Sell |
| 2018-04-04 | 開始されました | Guggenheim | Neutral |
| 2018-03-23 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2018-01-04 | ダウングレード | Northland Capital | Market Perform → Under Perform |
| 2017-09-28 | 繰り返されました | Wedbush | Outperform |
すべてを表示
Dexcom Inc (DXCM) 最新ニュース
Dexcom Inc. stock rises on Evercore ISI upgrade to Outperform with $90 target amid CGM market moment - AD HOC NEWS
Dexcom Inc. stock faces spotlight amid continuous glucose monitoring sector evolution and governance - AD HOC NEWS
Bronstein, Gewirtz & Grossman, LLC Is Investigating DexCom, Inc. (DXCM) And Encourages Investors to Connect - ACCESS Newswire
DexCom (NASDAQ:DXCM) Upgraded to "Outperform" at Evercore - MarketBeat
DXCM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
E. Ohman J or Asset Management AB Has $7.67 Million Stock Position in DexCom, Inc. $DXCM - MarketBeat
DexCom Inc. stock underperforms Monday when compared to competitors - MarketWatch
DexCom, Inc. $DXCM Shares Acquired by Gradient Investments LLC - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Encourages DexCom, Inc. (DXCM) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Devon Energy Corp stock eyes dividend surge amid Coterra merger push and rising oil prices - ad-hoc-news.de
Union Bancaire Privee UBP SA Increases Stake in DexCom - National Today
Union Bancaire Privee UBP SA Has $1.41 Million Stake in DexCom, Inc. $DXCM - MarketBeat
Here's why you should hold DexCom stock in your portfolio for now - MSN
Mizuho raises DexCom (DXCM) price target to $90 from $78 after earnings beat - MSN
DXCM Stock Price, Quote & Chart | DEXCOM INC (NASDAQ:DXCM) - ChartMill
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against DexCom, Inc. (DXCM) And Encourages Stockholders to Reach Out - ACCESS Newswire
Dexcom stock falls despite Q4 earnings beat, G7 rollout drives growth - MSN
Insider Selling: DexCom (NASDAQ:DXCM) EVP Sells 1,700 Shares of Stock - MarketBeat
Dexcom (DXCM) legal chief sells 1,700 shares in 10b5-1 trade - Stock Titan
Mizuho Markets Cayman LP Acquires 53,093 Shares of DexCom, Inc. $DXCM - MarketBeat
CIBC Private Wealth Group LLC Acquires 2,294,709 Shares of DexCom, Inc. $DXCM - MarketBeat
Block Trades: Will DexCom Inc outperform the market in YEAR2026 Chart Watch & Verified Momentum Stock Watchlist - baoquankhu1.vn
DXCM Stock Falls Despite FDA Clearance for Dexcom Smart Basal - MSN
DexCom Inc. stock outperforms competitors on strong trading day - MarketWatch
Bronstein, Gewirtz & Grossman, LLC Is Investigating DexCom, Inc. (DXCM) And Encourages Stockholders to Connect - ACCESS Newswire
DexCom, Inc. $DXCM Shares Purchased by Mizuho Markets Cayman LP - MarketBeat
Bank of Nova Scotia Trims Stake in DexCom - National Today
DexCom, Inc. $DXCM Shares Sold by Bank of Nova Scotia - MarketBeat
Fortrea, Alignment Healthcare, PacBio, DexCom, and Humana Stocks Trade Up, What You Need To Know - Yahoo Finance
[144] DEXCOM INC SEC Filing - Stock Titan
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now - Barchart
Is Dexcom (DXCM) Fairly Priced After Recent Share Price Pressure? - Yahoo Finance
Iron Triangle Partners LP Purchases New Shares in DexCom, Inc. $DXCM - MarketBeat
Holocene Advisors Invests $163.96M in DexCom - National Today
Holocene Advisors LP Makes New $163.96 Million Investment in DexCom, Inc. $DXCM - MarketBeat
Bamco Inc. NY Reduces Stock Position in DexCom, Inc. - National Today
DexCom, Inc. (DXCM) Showcases Next-Gen CGM Features at EASD 2025 - MSN
Cinctive Capital Management LP Takes $4.45 Million Position in DexCom, Inc. $DXCM - MarketBeat
Bamco Inc. NY Reduces Stock Position in DexCom, Inc. $DXCM - MarketBeat
This Biotech Stock Up Nearly 100% in a Year Has Drawn a New $20 Million Share Investment - The Motley Fool
DexCom, Inc. (DXCM) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Aristotle Atlantic Partners LLC Makes New $13.01 Million Investment in DexCom, Inc. $DXCM - MarketBeat
Is DexCom (DXCM) Fairly Priced After Recent Share Price Pullback? - simplywall.st
Prosight Management LP Boosts DexCom Stake by 178.9% - National Today
Prosight Management LP Acquires 125,217 Shares of DexCom, Inc. $DXCM - MarketBeat
Thematics Asset Management Has $24.38 Million Stock Position in DexCom, Inc. $DXCM - MarketBeat
Ossiam Has $18.15 Million Stake in DexCom, Inc. $DXCM - MarketBeat
Wealth Advisors of Tampa Bay LLC Has $660,000 Holdings in DexCom, Inc. $DXCM - MarketBeat
Sirios Capital Management Boosts DexCom Stake by 75% - National Today
Sirios Capital Management L P Acquires 145,682 Shares of DexCom, Inc. $DXCM - MarketBeat
Assessing DexCom (DXCM) Valuation As Conference Highlights Growth In Glucose Monitoring Technology - simplywall.st
Dexcom Inc (DXCM) 財務データ
収益
当期純利益
現金流量
EPS
0.30%
0.33%
大文字化:
|
ボリューム (24 時間):